Let me now when the sales start to pick up.
Then all this business about death spiral financing and dilution and consolidation will matter not.
I thought the fact that concrete mixed with the edencrete admixture was so much easier to work with, is a new and compelling reason to buy it.
On top of its inherent strengths, it's lower price and its great performance with salts and the scrapping of ploughs etc.
being easy to work with, to move around and smooth out as it is setting makes edencrete all that much better. Sales will climb more steeply from here.
I believe EDE is going back to shareholders one last time, in the hope that they do NOT need to use the death spiral finance.
They are trying to keep the company afloat the only way they can. Don't complicate it.
Just need to improve the sales. The same problem they have always had. The fact that it is actually easy to work with is the tipping point.
If this CR isn't a success then they will have to exercise the long state option.
But sales are going to pick up from here.
IMO.
- Forums
- ASX - By Stock
- EDE
- Ann: Trading Halt
Ann: Trading Halt, page-45
-
-
- There are more pages in this discussion • 203 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EDE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.427M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 204793284 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 10206803 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
66 | 204793284 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 10206803 | 10 |
0.003 | 51095595 | 28 |
0.004 | 8849367 | 7 |
0.005 | 360000 | 1 |
0.006 | 2831956 | 1 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
EDE (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online